芪苈强心胶囊与左西孟旦联合治疗充血性心力衰竭的疗效观察

薛强，高伟

（西京医院，陕西 西安，710032）

浏览次数：89次 下载次数：367次

摘要：

目的 探究芪苈强心胶囊与左西孟旦联合治疗充血性心力衰竭的疗效。方法 选取2013年2月至2016年2月于我院就诊的80例充血性心力衰竭患者，按照住院顺序将其分为对照组与观察组，各40 例。对照组采用左西孟旦治疗，观察组采用芪苈强心胶囊与左西孟旦联合治疗。观察两组患者的治疗总有效率及治疗前、后的心功能。结果 观察组患者治疗总有效率明显高于对照组（P<0.05）；治疗后，两组患者的心功能明显优于治疗前，且观察组明显优于对照组（P<0.05）。两组不良反应 发生率比较，差异不显著（P>0.05）。结论 芪苈强心胶囊联合左西孟旦治疗充血性心力衰竭的治疗效果好，安全性高，可促进患者心功能恢复，具有极大的推广价值。

关键词：芪苈强心胶囊；左西孟旦；充血性心力衰竭

中图分类号：R541.6文献标志码：A文章编号：2096-1413(2017)31-0014-02

Curative effect observation of Qili Qiangxin capsule combined with levosimendan on congestive heart failure
XUE Qiang, GAO Wei
(Xijing Hospital, Xi``an 710032, China)

ABSTRACT: Objective To investigate the curative effect of Qili Qiangxin capsule combined with levosimendan on congestive heart failure. Methods Eighty cases of patients with congestive heart failure in our hospital from February 2013 to February 2016 were selected and divided into control group and observation group according to the order of hospitalization, with 40 cases in each group. The control group was treated with levosimendan, while the observation group was treated with Qili Qiangxin capsule and levosimendan. The total effective rate of treatment and the cardiac function before and after treatment were observed in the two groups. Results The total effective rate of the observation group was significantly higher than that of the control group (P<0.05). After treatment, the cardiac functions of the two groups were significantly better than those before treatment, and those of the observation group were superior to the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion Qili Qiangxin capsule combined with levosimendan in the treatment of congestive heart failure has good effect and high safety, it can promote the cardiac function recovery of patients, which has great value to promote.
KEYWORDS: Qili Qiangxin capsule; levosimendan; congestive heart failure

参考文献：
[1] HADANO Y,OGAWA H,WAKEYAMA T,et al.Impact of milrinone on mitral annular velocity in patients with congestive heart failure[J].J Med Ultrason,2013,40(2):111-118.
[2] 李雄文,胡展瑞,罗洪民,等.芪苈强心胶囊治疗慢性心力衰竭疗效的Meta 分析[J].中国循证心血管医学杂志,2014,7(5):529-533.
[3] 咸慧霞,米娜,王同成,等.左西孟旦联合芪苈强心胶囊治疗充血性心力衰竭临床观察[J].山东医药,2015,55(41):53-54.
[4] 汪菁峰,周京敏,葛均波,等.芪苈强心胶囊治疗心力衰竭机制的研究进展[J].中西医结合心脑血管病杂志,2015,13(1):17-19.
[5] 李华.芪苈强心胶囊治疗慢性充血性心力衰竭的疗效评价[J].现代预防医学,2013,40(22):4281-4282,4285.
[6] 陈婕,陈兵勇.芪苈强心胶囊对心力衰竭患者心功能影响的超声研究[J].临床医学工程,2013,20(6):652-653.
[7] 王颖.硝普钠联合芪苈强心胶囊治疗慢性充血性心力衰竭的疗效评价[J].中国实用医药,2014,14(3):132-133.
[8] 王平,韩兰唐,张立民,等.芪苈强心胶囊对慢性充血性心力衰竭患者的疗效及脂联素水平的影响[J].中国药业,2015,24(10):47-49.
[9] 杨戈.中医药治疗慢性充血性心力衰竭的临床疗效分析[J].中国医药指南,2013,11(36):205-206.